Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Basic Science Investigations

  • You have access
    Evaluation of an 111In-DOTA–Rhenium Cyclized α-MSH Analog: A Novel Cyclic-Peptide Analog with Improved Tumor-Targeting Properties
    JianQing Chen, Zhen Cheng, Nellie K. Owen, Timothy J. Hoffman, Yubin Miao, Silvia S. Jurisson and Thomas P. Quinn
    Journal of Nuclear Medicine December 1, 2001, 42 (12) 1847-1855;
  • You have access
    Effects of Chemotherapeutic Agents on Expression of Somatostatin Receptors in Pancreatic Tumor Cells
    Barbara J. Fueger, Gerhard Hamilton, Markus Raderer, Thomas Pangerl, Tatjana Traub, Peter Angelberger, Gerhard Baumgartner, Robert Dudczak and Irene Virgolini
    Journal of Nuclear Medicine December 1, 2001, 42 (12) 1856-1862;
  • You have access
    Imaging of Striatal Dopamine D2 Receptors with a PET System for Small Laboratory Animals in Comparison with Storage Phosphor Autoradiography: A Validation Study with 18F-(N-Methyl)Benperidol
    Susanne Nikolaus, Rolf Larisch, Markus Beu, Henning Vosberg and Hans-Wilhelm Müller-Gärtner
    Journal of Nuclear Medicine November 1, 2001, 42 (11) 1691-1696;
  • You have access
    The Humoral Immune Response to Macrocyclic Chelating Agent DOTA Depends on the Carrier Molecule
    Maria Elisa Perico, Marco Chinol, Angelo Nacca, Elena Luison, Giovanni Paganelli and Silvana Canevari
    Journal of Nuclear Medicine November 1, 2001, 42 (11) 1697-1703;
  • You have access
    Reconstruction of Dynamic Renal Tomographic Data Acquired by Slow Rotation
    Arkadiusz Sitek, Grant T. Gullberg, Edward V.R. Di Bella and Anna Celler
    Journal of Nuclear Medicine November 1, 2001, 42 (11) 1704-1712;
  • You have access
    In Vitro Investigations of Tumor Targeting with 99mTc-Labeled Antisense DNA
    Yu-Min Zhang, Yi Wang, Ning Liu, Zhi-Hong Zhu, Mary Rusckowski and Donald J. Hnatowich
    Journal of Nuclear Medicine November 1, 2001, 42 (11) 1660-1669;
  • You have access
    Correlation of Tumor and Whole-Body Dosimetry with Tumor Response and Toxicity in Refractory Neuroblastoma Treated with 131I-MIBG
    Katherine K. Matthay, Colleen Panina, John Huberty, David Price, David V. Glidden, H. Roger Tang, Randall A. Hawkins, Janet Veatch and Bruce Hasegawa
    Journal of Nuclear Medicine November 1, 2001, 42 (11) 1713-1721;
  • You have access
    Sense, Antisense, and Common Sense
    Jean-Luc C. Urbain
    Journal of Nuclear Medicine November 1, 2001, 42 (11) 1670-1672;
  • You have access
    Biodistribution and Dosimetry of 99mTc-RP527, a Gastrin-Releasing Peptide (GRP) Agonist for the Visualization of GRP Receptor–Expressing Malignancies
    Christophe Van de Wiele, Filip Dumont, Rudi A. Dierckx, Susan H. Peers, John R. Thornback, Guido Slegers and Hubert Thierens
    Journal of Nuclear Medicine November 1, 2001, 42 (11) 1722-1727;
  • You have access
    Metabolites of 18F-FDG and 3-O-11C-Methylglucose in Pig Liver
    Dirk Bender, Ole L. Munk, Hong-Qiang Feng and Susanne Keiding
    Journal of Nuclear Medicine November 1, 2001, 42 (11) 1673-1678;

Pages

  • Previous
  • Next
  • 1
  • …
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • …
  • 174
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire